Nanomedicine · 2024 · 14 citations · 51 references
PharmacyPharmaceuticsPharmacologyBiocompatibilityDrug DeliveryNanomaterialsCancer NanomedicineDrug EncapsulationNanomaterials For Drug DeliveryNanomedicineNanoparticle FormulationsPolymeric NanoparticlesBiocompatible Polymeric NanoparticlesChitosan-based NanomaterialsDrug Delivery NanocarriersEntrapmentMucoadhesion MechanismsNanoparticle BiocompatibilityPh-responsive Polymeric NanoparticlesPh-sensitive Nanoparticles
Aim: This study aimed to develop and evaluate pH-sensitive docetaxel-loaded thiolated hyaluronic acid (HA-SH) nanoparticles (NPs) for targeted treatment of colon cancer. Materials & methods: HA-SH, synthesized via oxidation and subsequent covalent linkage to cysteamine, served as the precursor for developing HA-SH NPs through polyelectrolyte complexation involving chitosan and thiol-bearing HA. Results & conclusion: HA-SH NPs displayed favorable characteristics, with small particle sizes (184–270 nm), positive zeta potential (15.4–18.6 mV) and high entrapment efficiency (91.66–95.02%). In vitro, NPs demonstrated potent mucoadhesion and enhanced cytotoxicity compared with free docetaxel. In vivo assessments confirmed safety and biocompatibility, suggesting HA-SH NPs as promising pH-sensitive drug carriers with enhanced antitumor activity for colorectal cancer treatments.
51
Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting
Amol Paharia, Awesh K. Yadav, Sunil K. Jain et al. · AAPS PharmSciTech · 2007 · 181 citations · Full text
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
M. Subudhi, Ankit Jain, Ashish Jain et al. · Materials · 2015 · 161 citations · Full text
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration
Eun Hye Lee, Hyungjun Kim, In‐Hyun Lee et al. · Journal of Controlled Release · 2009 · 142 citations
Medicine, Oncology, Pharmacology +16